Hemgenix, World’s Most Expensive Drug, Approved by US FDA To Treat Hemophilia, Costs Over Rs 28 Crore per Dose

Hemgenix, World's Most Expensive Drug, Approved by US FDA To Treat Hemophilia, Costs Over Rs 28 Crore per Dose

According to reports, the U.S. Food and Drug Administration recently approved Hemgenix, a new drug to treat hemophilia. Reportedly, manufacturer CSL Behring has set the price of the drug at $3.5 million per treatment, thereby making it the most expensive drug in the world. As per reports, the Hemgenix drug is a gene therapy to treat adults with hemophilia B. The hemophilia B is a genetic bleeding disorder due to which people are not able to produce a protein that is needed to create blood clots. About 1 in 40,000 people have the disease, most of whom are men. US FDA Lifts Hold on Bharat Biotech’s COVID-19 Vaccine Covaxin’s Clinical Trials in America.

FDA Approves Drug To Treat Hemophilia

(Fresh Headline brings you all the latest breaking news, viral trends and information from social media world, including Twitter, Instagram and Youtube. The above post is embeded directly from the user’s social media account and Fresh Headline Staff may not have modified or edited the content body. The views and facts appearing in the social media post do not reflect the opinions of Fresh Headline, also Fresh Headline does not assume any responsibility or liability for the same.)